tells

Submit complete safety data: CDSCO panel tells Novartis on Remibrutinib

by April 23, 2023, 1:12 pm

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has recommended the drug maker Novartis to submit complete safety data of the ongoing study of Bruton’s tyrosine kinase inhibitor Remibrutinib till date for further review by the committee to allow an extension of the current study. Bruton’s tyrosine […] More

in Health care

Revise Phase I/II CT protocol: CDSCO panel tells Serum Institute of India on Dengue Tetravalent Vaccine

by April 17, 2023, 3:25 pm

New Delhi: Regarding the Phase I/II clinical trial of Dengue Tetravalent Vaccine (Live, Attenuated), the Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization (CDSCO) has opined the vaccine major Serum Institute of India to revise the Phase I/II clinical trial protocol. This came after the firm presented its proposal to conduct of […] More

in Health care

Present More Data On Almitrine, Ifenprodil: CDSCO Panel Tells CDRI-CSIR

by April 16, 2023, 3:26 pm

New Delhi: After deliberating the Phase III clinical trial protocol of the pulmonary drug Almitrine and Ifenprodil, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has opined the Central Drug Research Institute- Council of Scientific & Industrial Research (CDRI-CSIR) to submit preclinical data, proof of the concept for the […] More

in Health care

Revise Phase III CT protocol: CDSCO Panel Tells Dr Reddy’s over Tegoprazan

by April 15, 2023, 4:19 pm

New Delhi: In response to the proposal to conduct a Phase III clinical trial presented by the drug major Reddy’s Laboratories, the Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization (CDSCO) has opined the firm to revise the protocol of Phase III clinical trial of the drug Tegoprazan with respect to the […] More

in Health care

Revise Phase IV CT Protocol: CDSCO panel tells Zydus Lifesciences on Typhoid Vi Conjugate Vaccine with Yellow Fever Vaccine

by April 15, 2023, 3:50 pm

New Delhi: In response to the drug major Zydus Life Sciences’ proposal to conduct Phase IV clinical for Typhoid Vi Conjugate Vaccine I.P.(TCV) with Yellow Fever Vaccine(YFV), the Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization (CDSCO) has opined the firm to revise the Phase IV clinical trial protocol. This came after […] More

in Celebrities

Nysa Devgan Tells Paparazzi How To Pronounce Her Name: “Mera Naam Nissa Hai”

by April 14, 2023, 9:13 am

Bollywood stars Kajol and Ajay Devgn’s daughter Nysa Devgan, who is frequently photographed by Mumbai’s paparazzi, stepped out for dinner with her bestfriend Orhan Awatramani on Thursday night. As Nysa was filmed making her way out of the Mumbai eatery, the paparazzi chanted her name in unison. The paparazzi were referring to her as “Naee-sa.” […] More

in Health care

Fortis doctor accused of negligence does not have recognised qualification to be Child Specialist: NMC tells Delhi HC

by April 14, 2023, 7:49 am

New Delhi: Scrutiny into the PG degrees of 2 senior doctors of Fortis Hospital has revealed that one of the two doctors, accused of medical negligence due to which a newborn fell into a vegetative state, does not have recognised qualification to be called a child specialist. Even the additional qualification of another doctor making […] More

Twitter Tells Karnataka HC Its Petition Against MeitY’s Content Takedown Orders Are Maintainable

by April 13, 2023, 4:29 am

Social media company Twitter on Wednesday informed the High Court of Karnataka that its petition challenging the various takedown orders of the Ministry of Electronics and Information Technology (MeitY) was maintainable, as the concept of reasonableness in Article 19 of the Constitution of India pertaining to Freedom of Speech was applicable to it. Advocate Manu […] More

in Health care

Set Example, Say NO to Alcohol in Medical Conferences, Workshops, Seminars, CME: DGHS tells Doctors

by April 6, 2023, 11:28 am

New Delhi: Asking doctors to set an example of good habit that others can follow, the Director General of Health Services (DGHS), under the Union Ministry of Health and Family Welfare (MoHFW) has directed them to avoid alcohol in Medical Conference/ Workshop/ Seminar/CME. Writing to all the Medical Associations across the country, DGHS Prof. (Dr.) Atul […] More

in Health care

Procure injection to treat 4-year-old boy suffering from horseshoe kidney disorder, Delhi HC tells AIIMS

by April 6, 2023, 7:25 am

New Delhi: While considering the plea involving the four-year-old child suffering from a horseshoe kidney disorder, the Delhi High Court has directed the All India Institute of Medical Sciences (AIIMS) New Delhi to urgently import an injection named Dexell required for treating the boy as the same is not available in the country. The Delhi […] More

in Health care

Conduct PK study for repeated dose and Phase III CT : CDSCO Panel tells Sun Pharma on Psoriatic drug combination

by April 1, 2023, 3:44 pm

New Delhi: Rejecting the drug major Sun Pharma’s proposal for a Phase III clinical trial study waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has opined that the firm should conduct the pharmacokinetic (PK) study for repeated dose and the Phase III clinical trial of the fixed-dose combination […] More

in Health care

All SAEs including death should be reported: CDSCO Panel tells AstraZeneca about Durvalumab

by March 25, 2023, 4:29 pm

New Delhi: Granting the protocol amendment proposal presented by drug major AstraZeneca for anticancer drug Durvalumab, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has stated that all serious adverse events (SAEs) including death irrespective of its cause should be reported to CDSCO as per provision of New Drugs […] More

Latest stories

Add to Collection

No Collections

Hey Friend!Before You Go…

Hey Friend!
Before You Go…